BackTitan Medical Overview

Titan Medical Profit Margin

Titan Medical (TMDI) has a profit margin of -211.2%, below the Healthcare sector average of 13.89%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Sep 2022

Annual Profit Margin (TTM)

-211.20%
5.60% YoY

Trailing 12 months ending Sep 2022

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Titan Medical (TMDI) FAQ

The latest profit margin for TMDI is -211.2% as of September 2022. That compares with -223.74% in the prior-year period — up 5.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Titan Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, TMDI's profit margin moved from -223.74% to -211.2% — a 5.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Titan Medical's valuation or profitability profile.

Against Healthcare companies, TMDI currently prints -211.2% for profit margin, while the sector average sits near 13.89%. That is roughly 1621.1% below the sector mean. Large gaps often invite a closer look at Titan Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Titan Medical converts resources into returns. At -211.2%, TMDI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -223.74% in the prior-year period — up 5.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TMDI's profit margin (-211.2%), review year-over-year change from -223.74%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.